A detailed history of Captrust Financial Advisors transactions in Certara, Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 21,766 shares of CERT stock, worth $240,078. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,766
Previous 18,980 14.68%
Holding current value
$240,078
Previous $339,000 11.21%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$13.36 - $18.94 $37,220 - $52,766
2,786 Added 14.68%
21,766 $301,000
Q1 2024

May 15, 2024

SELL
$15.65 - $19.45 $15,837 - $19,683
-1,012 Reduced 5.06%
18,980 $339,000
Q4 2023

Feb 14, 2024

BUY
$12.12 - $18.19 $27,233 - $40,872
2,247 Added 12.66%
19,992 $351,000
Q3 2023

Nov 14, 2023

BUY
$13.9 - $19.58 $8,687 - $12,237
625 Added 3.65%
17,745 $258,000
Q2 2023

Aug 14, 2023

SELL
$16.89 - $24.64 $59,148 - $86,289
-3,502 Reduced 16.98%
17,120 $311,000
Q1 2023

May 15, 2023

BUY
$15.9 - $24.72 $40,147 - $62,418
2,525 Added 13.95%
20,622 $497,000
Q4 2022

Feb 15, 2023

BUY
$10.7 - $17.84 $193,637 - $322,850
18,097 New
18,097 $290,000
Q2 2022

Aug 16, 2022

BUY
$16.75 - $22.54 $77,083 - $103,729
4,602 Added 99.44%
9,230 $198,000
Q1 2022

May 16, 2022

BUY
$17.89 - $28.73 $47,676 - $76,565
2,665 Added 135.76%
4,628 $99,000
Q4 2021

Feb 14, 2022

BUY
$26.1 - $45.21 $27,639 - $47,877
1,059 Added 117.15%
1,963 $56,000
Q3 2021

Nov 16, 2021

BUY
$24.46 - $38.41 $7,240 - $11,369
296 Added 48.68%
904 $30,000
Q2 2021

Aug 16, 2021

BUY
$24.79 - $33.31 $1,413 - $1,898
57 Added 10.34%
608 $17,000
Q1 2021

May 17, 2021

BUY
$25.58 - $39.0 $8,978 - $13,689
351 Added 175.5%
551 $15,000
Q4 2020

Feb 16, 2021

BUY
$33.59 - $40.18 $6,718 - $8,036
200 New
200 $7,000

Others Institutions Holding CERT

About Certara, Inc.


  • Ticker CERT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 159,899,008
  • Market Cap $1.76B
  • Description
  • Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...
More about CERT
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.